Erasca IncERAS
▼ ネガティブ規制関連度
Class action lawsuit alleges failure to disclose patent infringement risk; stock price dropped on disclosure of RevMed's legal letter.
資産への影響 2
Biotech & Genomic Medicine
Erasca Inc
Revolution Medicines IncRVMD
▲ ポジティブ規制関連度
RevMed is the plaintiff alleging patent infringement and trade secret misappropriation against Erasca, which could benefit RevMed.